Topline data were announced from a phase 3 trial evaluating luspatercept-aamt plus Janus kinase 2 inhibitor (JAKi) therapy in adults with myelofibrosis-associated anemia receiving red blood cell (RBC) ...

The latest Market Talks covering Basic Materials. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ...

The price ceiling on Russian oil approved by the EU will be reviewed every three months. It can either increase or decrease ...

“If it is to continue this pace of outperformance vis-a-vis its Big Six peers, then it needs to really turn on the ...